HomeELTP • OTCMKTS
add
Elite Pharmaceuticals, Inc. Common Stock
Previous close
$0.62
Day range
$0.61 - $0.63
Year range
$0.12 - $0.75
Market cap
658.91M USD
Avg Volume
4.41M
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 18.88M | 33.36% |
Operating expense | 4.71M | 4.22% |
Net income | -11.04M | -173.90% |
Net profit margin | -58.45 | -155.41% |
Earnings per share | — | — |
EBITDA | 3.91M | 73.08% |
Effective tax rate | -15.94% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.55M | 10.41% |
Total assets | 88.20M | 24.72% |
Total liabilities | 40.93M | 59.73% |
Total equity | 47.27M | — |
Shares outstanding | 1.07B | — |
Price to book | 15.44 | — |
Return on assets | 9.90% | — |
Return on capital | 13.55% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -11.04M | -173.90% |
Cash from operations | 1.46M | 717.47% |
Cash from investing | 17.56K | — |
Cash from financing | -320.69K | -78.66% |
Net change in cash | 1.15M | 377.71% |
Free cash flow | 400.54K | -46.84% |
About
Founded
1997
Headquarters
Website
Employees
64
